Skip to main content
logo
Synmosa Biopharma Corporation (TPEX:4114)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
33.35
-0.20 (-0.60%)
At close: Jul 9, 2026

Revenue by Segment

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Generic Drugs Segment
6.00B5.40B4.96B4.24B3.15B
Generic Drugs Segment Growth
11.16%8.78%17.05%34.70%7.61%
Active Pharmaceutical Ingredients Segment
467.25M363.24M325.78M234.87M119.57M
Active Pharmaceutical Ingredients Segment Growth
28.64%11.50%38.71%96.43%-21.63%
Intersegment Income
-276.90M-210.22M-146.19M-86.89M-31.13M
Total
6.19B5.55B5.14B4.39B3.23B
Total Growth
11.53%7.96%17.19%35.59%6.47%

Revenue by Geography

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Taiwan
5.24B4.76B4.45B3.88B2.81B
Taiwan Growth
10.01%6.97%14.83%37.79%7.43%
China
698.28M564.55M450.98M271.73M293.58M
China Growth
23.69%25.18%65.97%-7.44%-2.68%
United States
25.60M2.21M28.78M62.74M8.66M
United States Growth
1060.56%-92.34%-54.12%624.84%-
Canada
11.15M2.14M15.50M34.97M30.29M
Canada Growth
420.10%-86.16%-55.68%15.43%157.61%
Thailand
45.81M29.70M54.56M39.60M23.16M
Thailand Growth
54.23%-45.56%37.79%70.99%-10.52%
Malaysia
28.43M34.36M36.45M30.75M19.41M
Malaysia Growth
-17.24%-5.73%18.54%58.38%1.67%
Singapore
80.00M75.89M41.91M--
Singapore Growth
5.43%81.06%---
Other
61.76M79.11M60.80M70.10M46.47M
Other Growth
-21.93%30.12%-13.28%50.85%-23.80%
Total
6.19B5.55B5.14B4.39B3.23B
Total Growth
11.53%7.96%17.19%35.59%6.47%